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Abstract
Background: Sickle cell anemia (SCA) is a common genetic disease in Nigeria. Past studies from West Africa
focused on isolated aspects of its medical and surgical presentations. To the best of our knowledge, the musculo-
skeletal presentations amongst Nigerians with SCA have not been documented in a single all encompassing study.
This work aims to prospectively document the musculo-skeletal disease burden among SCA patients.
Methods: In a prospective study of 318 consecutive patients with genotype-confirmed SCA at the Lagos University
Teaching Hospital (LUTH), the musculo-skeletal pathologies, anatomic sites, grade of disease, age at presentation
and management outcome were recorded over a one-year period. Data obtained were analyzed using Epi-Info
software version 6.0. Data are presented as frequencies (%) and mean values (SD) as appropriate.
Results: The HbSS genotype occurred in 296 (93.0%), while 22 (7.0%) were HbSC. 100 (31.4%) patients with
average presenting haemoglobin concentration of 8.2 g/100 ml in the study group, presented with 131 musculo-
skeletal pathologies in 118 anatomic sites. Osteomyelitis 31 (31%) and septic arthritis 19 (19%) were most
commonly observed in children less than 10 years. Skin ulcers and avascular necrosis (AVN) occurred
predominantly in the older age groups, with frequencies of 13 (13.0%) and 26 (26.0%) respectively. 20 (71.5%) of
diagnosed cases of AVN presented with radiological grade 4 disease. The lower limbs were involved in 84 (71.1%)
of sites affected. Lesions involving the spine were rare 11 (0.9%). Multiple presentations occurred in 89 (28.0%) of
patients; 62 (69.7%) of which were children below 10 years.
Conclusions: Musculo-skeletal complications are common features of sickle cell anaemia seen in 31.4%. Infectious
aetiologies predominate with long bones and joints of lower limbs more commonly affected by osteomyelitis and
septic arthritis. Healthcare providers managing SCA should be aware of the potential morbidity and mortality of
these conditions to ensure early diagnosis and adequate management.
Background
Sickle cell disease (SCD) is a group of inherited haemo-
globinopathies occurring mainly in Negroid populations
in and out of Africa, characterized by a predominance
of haemoglobin S (HbS) in the erythrocytes [1]. It was
first recognized by James B. Herrick [2] in 1910 when
he described abnormal sickle-shaped cells in an anaemic
patient of Negroid extraction. Pauling et al [3] discov-
ered the presence of abnormal haemoglobin in patients
with sickle cell disease in 1949. SCD is the most fre-
quent haemoglobinopathy in the world [4,5] and
currently the second most common genetic disease after
Down’s syndrome [5]. Sickle cell disease is said to affect
between 2-3% of the Nigerian population [1].
Sickle cell anaemia (SCA) occurs when there is homo-
zygote HbSS or composite heterozygote HbSC [1]. It is
primarily a disease of haemopoetic system in which the
skeleton bears the brunt of its complications [6]. Bone
changes in SCA occur due to marrow hyperplasia, tissue
ischaemia and infarction due to vaso-occlusion [7-9].
Musculo-skeletal manifestations constitute up to 80% of
indications for presentation in hospital in SCA during
their life time [10-14]. Pain is the principal complaint
either acute following skeletal or soft tissue infarction or
chronic secondary to avascular necrosis of bone at var-
ious joints [15]. Most studies of musculo-skeletal
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selected disease conditions [8,10,16-19].
SCA causes a heavy burden on the society by the high
morbidity and premature death associated with it [20].
This study was designed to prospectively document,
using a comprehensive approach, the spectrum and fre-
quency of musculo-skeletal presentations among
patients with SCA. This would provide useful data on
the burden of musculo-skeletal disease in SCA, for
further research, infrastructural and manpower planning
towards appropriate care delivery.
Methods
This prospective study was conducted over a 12-month
period between June 2000 and May 2001 at Lagos Uni-
versity Teaching Hospital (LUTH), Lagos, Nigeria.
LUTH is one of the foremost tertiary hospitals in
Nigeria. The study protocol was approved by the Health
Research and Ethics Committee of the hospital.
Informed consent was obtained from all study partici-
pants or their proxies.
Cases included were consecutively presenting patients
with Hb genotype SS or SC attending one of 4 sites in
the hospital: orthopaedic outpatient clinic, accident and
emergency department, haemotology clinic (adult SCD
clinic) and paediatric outpatient department. Through a
pre-arranged notification network, the investigators were
informed of any case of SCA presenting during the
study period, and each patient was then evaluated by
one of the investigators using the standardized format
developed for the study. Musculo-skeletal complaints
were defined as any problem affecting bones or/and its
associated soft tissues. Patients with SCA with congeni-
tal musculo-skeletal anomalies were excluded.
Clinical evaluation and relevant investigations were
carried out as part of standard management of these
patients to arrive at a diagnosis by the authors. The
d i a g n o s i so fA V Nw a sm a d eu s i n gp l a i nx - r a y sa st h e
institution at the time of study had no facilities for CT,
MRI or Isotope scan. This was stated as the main reason
for the absence of stage 1 disease in our study. All
patients with a diagnosis of septic arthritis had emer-
gency arthrotomy and drainage. Aspirates were sent for
culture and antibiotic sensitivity. Active ulcers were con-
sidered as ulcers but those with unspecific scars on the
ankles were not considered as such. Osteomyelitis was
diagnosed based on clinical evaluation, needle puncture
and intra operative aspirate of purulent fluid with posi-
tive cultures.
A standard proforma was filled following detailed his-
tory and physical examination with requisite investiga-
tions to confirm the diagnosis. Variables recorded
included age, sex, weight, height, genotype, anatomic
site(s) involved, clinical features and the diagnosis.
Data obtained were analyzed using Epi-Info software
version 6.0. Data are presented as frequencies (%) and
mean values (SD) as appropriate, and compared using
either the chi square test (for proportions) or student’s
T test for mean values. P < 0.05 is taken as statistically
significant.
Results
Demography
Three hundred and eighteen patients with SCA were
studied. 100 (31.4%) patients with average presenting
haemoglobin concentration of 8.2 g/100 ml had 131
musculo-skeletal presentations at 118 anatomic sites. 60
(60.0%) of these were males and 40 (40.0%) were
females, giving a male: female ratio of 1.5:1. The ages of
all the patients ranged between 1 and 45 years, with a
mean of 14.2 ± 11.5 years. Forty-six (46.0%) of the
patients were aged below 10 years, while 52 (52.0%)
were aged between 11 - 40 years. Two (2.0%) were aged
above 40 years. Of the 100 patients with musculo-skele-
tal features studied, 93(93.0%) had HbSS genotype while
7(7.0%) had SC. (Table 1).
Infectious and non-infectious spectrum of
musculoskeletal disorders
Table 2 shows the frequency distribution of 131 mus-
culo-skeletal presentations of SCD documented. Osteo-
myelitis accounted for 49 (37.4%), followed by avascular
n e c r o s i s( A V N )2 8( 2 1 . 4 % )a n ds e p t i ca r t h r i t i s2 0
(15.3%). 25 (51.0%) of osteomyelitis were caused by sta-
phylococcus species, 16 (32.7%) by salmonella, 4 (8.2%)
by haemophilus and 3 (6.1%) by streptococcus. No
organism was isolated in one case. All cases of AVN
Table 1 Demographic parameters and genotype of
patients with musculo-skeletal presentation
Parameter No %
Males, 60 60.0%
Female, 40 40.0%
M: Female ratio 1.5:1 -
Age range, yrs 1 - 45 -
Mean age, yrs 14.2 ± 11.5 -
Age (yrs)
< 10 46 46.0%
11 - 20 27 27.0%
21 - 30 18 18.0%
31 - 40 7 7.0%
> 40 2 2.0%
Genotype
SS 93 93.0%
SC 7 7.0%
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disease (additional file 1: Figure S2) in 20 (71.5%) cases,
7 (25.0%) in grade 3, 1 (3.5%) in grade 2 (additional file
1: Figure S2), while no patient presented with grade 1
disease. Table 3 shows the age distribution of the var-
ious presentations. Osteomyelitis (p = 0.00002), septic
arthritis (p = 0.000005) and pathological fractures (p =
0.049) were significantly more common in patients
under the age of 10 years, while AVN (p = 0.000007)
and leg ulcers (p = 0.00001) were significantly more
common in older ages. Multiple presentations of SCA
w e r eo b s e r v e di n2 8( 2 8 . 0 % )p a t i e n t s .A ss h o w ni nF i g -
ure 1, 20 (71.4%) of these multiple presentations
o c c u r r e di np a t i e n t sa g e dl e s s than 10 years, 6 (21.4%)
in those aged between 11 and 20 years and 2 (7.2%) in
those over 20 years (p = 0.003).
Regional anatomic location of musculo-skeletal
presentations
One hundred and eighteen sites were involved in the
study population with 84 (71.2%) occurring in the lower
limbs, 33 (28.0%) in upper limbs and 1 (0.8%) in the
spine. An analysis of the pattern of regional anatomic
involvement according to age is shown in Table 4. 25
(75.8%) of the cases in the upper limb occurred in
patients aged less than 10 years, with 8 (24.2%) occur-
ring in other age groups. These differences were found
to be statistically significant with a p-value of 0.00008.
Osteomyelitis affected 49 cases, with the distribution as
follows: femur 20 (40.8%), tibia 14 (28.6%), humerus 11
(22.0%) and radius 4 (8.2%). Septic arthritis was found
in the hip joint in 8 (40.0%) cases, followed by the knee
5 (25.0%), elbow 4 (20.0%), shoulder 2 (10.0%) and ankle
1(0.5%). The humerus was pathologically fractured in 5
(50.0%), femur (2/10), tibia (2/10) and radius (1/10)
were similarly affected.
Discussion
The natural history of SCA is associated with a high
morbidity and mortality [20], although close surveil-
lance, prevention, and early detection of complications
can improve outcomes. High morbidity and mortality in
SCA is due, in part, to the increased proneness to infec-
tion [1], particularly in our environment where commu-
nicable diseases are prevalent. In this present study, it is
thus not surprising that the most frequently encoun-
tered underlying aetiology of musculoskeletal presenta-
tions was infection. Presentations directly related to
infections range between 11 - 61% in various studies
Figure 1 Frequency (%) of multiple and single musculoskeletal presentations by age group of patients in SCA. Multiple presentations
(>1) predominate in age group 1-10 years.
Table 2 Distribution of musculo-skeletal presentations of
patients
Disorder Frequency Percentage
Dactylitis 10 7.6
Osteomyelitis 49 37.4
Septic Arthritis 20 15.3
Ulcers 14 10.7
Avascular necrosis 28 21.4
Pathological fracture 10 7.6
Total 131 100
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been attributed to several factors, prominent among
which are defective immune mechanism and functional
asplenia [1,16,18,22]. Meticulous care for these patients
as well as improved health promotion and health seek-
ing behavior would reduce the morbidity and mortality
of this primeval condition.
Of 318 patients with SCA we studied, 31.4% had mus-
culo-skeletal presentations. This figure is lower than that
reported by Benneth and Namyak in 1990[12]. The male
preponderance found in this study is in keeping with pre-
vious studies [12-14]. An overwhelming majority of
patients in this study were below 40 years with only 2%
over that age. This may be due to reduced life expectancy
in SCA patients as had been documented in Cameroun
[23] and Senegal [24]. This differs sharply from findings
in the United States where 50%w e r eo v e r4 0y e a r s[ 2 5 ] .
Poor life expectancy among SCA patients in sub-saharan
A f r i c am a yb er e l a t e dt of a c t o r sl i k et h ea b s e n c eo f
hydroxyurea therapy that may improve survival [26] or
low educational attainment, poverty and limited access to
medical facilities among these patients [27]. The predo-
minance of young patients may also be due to differences
in health seeking behaviour between the younger, more
active persons with SCA, and the older patients with
SCA. The higher frequency of HbSS genotype in this
study is in keeping with earlier reports which showed
that this is the commonest variant of SCA among
Nigerians [13]. Our observed 7.0% frequency of HbSC
had been previously reported in West Africa [13].
Osteomyelitis is a major presentation of SCA and
accounted for one-third of cases in this study. This is
however lower than 61.0% reported among Saudis [12]
but comparable to 29.0% reported by Mijiyawa in a
neigbouring West African country [28]. The femur and
tibia were the most frequently involved bones followed
by the humerus. This pattern had been reflected in
other studies [16,29,30]. Septic arthritis, another major
infective presentation is reported to represent 6-11% of
bone and joint manifestations of SCA [11,31,32]. The
relatively higher value of 15.3% found in this study may
not be unrelated to the preponderance of young
patients, who are more prone to infections; low socioe-
conomic status [33,34] and the poor sanitary living con-
ditions of most of these patients [33], as well as
ineffective enforcement of environmental sanitation laws
in our environment.
SCA is the commonest cause of AVN in Nigeria
[9,17]. AVN complicating SCA has previously been
reported to occur in 3 - 19% of SCA patients [12,17]. In
this study, a higher percentage was recorded, mostly
presenting in late stages as was the case in a Yaounde
study by Bahebeck et al [23] in 2004. This may be
because first line medical care givers missed the diagno-
sis at earlier stages. It may also be due to patients pre-
senting first to traditional bone setters, churches and
mosques only to come to hospitals at late stages. Lack
of modern diagnostic facilities and/or relatively high
cost of orthodox medical care in Nigeria for most of
these patients may have contributed to this. There is
therefore a need to mount education and awareness
campaigns for the sickle cell disease population, their
medical care givers and the society in general on the
need to seek and give appropriate care early. This is
because there is no doubt that there is upward surge in
life expectancy of SCA patients due to better under-
standing and correct management of the complications
[6]. Also provision of modern diagnostic facilities such
as magnetic resonance imaging at affordable costs and
with improved accessibility would help in the recogni-
tion of the early stages of this disease.
Pathological fractures were seen in 7.6% of our
patients, a figure higher than 4% reported by Omojola et
al [17]. Surprisingly, there was a preponderance of affec-
tation of the humerus compared to the femur and tibia,
despite the fact that most presentations were seen in the
l o w e rl i m b s .T h es m a l l e rn u m b e ro ff r a c t u r e si nt h e
lower limbs may be ascribed to the compulsive reduc-
tion in physical activity of the lower limbs during peri-
ods of significant bone pain, while patients may
continue the use of upper limbs even with severe disease
and pain.
Table 3 Distribution by age of presentations
Disorder <10 years
N (%)
11-20
N (%)
>2 0
N (%)
Total P-value
Dactylitis 10 - - 10 N/A
Osteomyelitis 31 (63.3) 15 (30.6) 3 (6.1) 49 P =
0.00002
Septic
Arthritis
19 (95.0) 1 (5.0) - 20 P =
0.000005
Ulcers 1 (7.1) 2 (41.3) 11 (78.6) 14 P =
0.00001
Avascular
necrosis
2 (7.2) 13 (46.4) 13 (46.4) 28 P =
0.000007
Pathological 8 (80.0) 2 (20.0) - 10 P = 0.049
Total 71 33 27 131
Table 4 Distribution by age of regional anatomic
involvement
Site <10 years
N (%)
11 - 20
years
N (%)
11 - 20
years
N (%)
Total (%)
Upper Limbs 25 (75.8) 6 (18.2) 2 (6.0) 33 (28.0)
Lower Limbs 33 (39.2) 26 (31.0) 25 (29.8) 84 (71.1)
Spine - - 1 (0.09) 1 (0.09)
Total 58 (49.2) 32 (27.1) 28 (23.7) 118 (100)
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between infectious presentations such as osteomyelitis
and septic arthritis with less than 10 year olds, as well
as between non-infectious presentations such as AVN
and skin ulcers with older patients. AVN and skin ulcers
are mostly due to progressive devascularisation of
affected areas. Their preponderance in older patients
may result over the years of life from chronic anaemia
causing marrow hyperplasia as well as red cell sickling
secondary to hypoxia leading to bone infarcts [35].
These infarcts are typically in areas supplied by end
arteries [35].
Conclusions
This study has shown that osteomyelitis remains the
most common musculo-skeletal presentation of SCA
and occurs predominantly in patients below the age of
10 years. The predominant presentation in adolescents
is AVN, with majority of them presenting in the late
stage. Multiple presentations are seen in all groups and
this calls for a detailed assessment of SCA patients by
health care professionals in order to avoid cases of
missed diagnosis.
Additional file 1: Additional radiograph figures. Figure S1 - Antero-
posterior plain radiograph of the pelvis showing stage III. AVN on the
right hip and stage II AVN on the left hip. Figure S2 - Antero-posterior
plain radiograph of the pelvis showing stage IV. AVN on the right hip.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1749-799X-5-2-
S1.DOC]
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